However, studies from 1997 to 2012 suggested that obesity rates began rising after we lowered red meat and whole-fat dairy consumption and substituted butter with margarine
This synthetic compound is examined as a triple receptor agonist acting at the GLP-1, GIP, and glucagon receptors
Professor Linong Ji of Peking University Peoples Hospital, the principal investigator of the study, stated, These results represent a case in which a biased GLP-1 agonist has demonstrated clinical superiority over existing therapies and added, It could set a new standard in the paradigm of obesity and metabolic disease treatment. HK inno.N CEO Kwak Dal-won said, This presentation reconfirmed the potential and promise of Ecnoglutide, adding, The company will do its utmost in new drug development to offer a new treatment option to patients in Korea. Kim Min-beom AI , .
However, symptoms may appear even below 350 pg per mL in some individuals